Dr Natalie Ngoi is a Consultant Medical Oncologist with a keen interest in developmental therapeutics and a subspecialty interest in Gynecologic and Genitourinary Cancers. She graduated with Honours from the Yong Loo Lin School of Medicine at the National University of Singapore in 2012 and continued her post-graduate training in Internal Medicine at the National University Health System Singapore. Dr Ngoi completed her Medical Oncology fellowship training at the National University Health System in Singapore in 2018, and is accredited by ACGME-I, the Specialist Accreditation Board and the Singapore Medical Council.
In 2019, Dr Ngoi was awarded the National Medical Research Council Singapore Research Training Fellowship Grant and furthered her training in early drug development at the Department of Investigational Cancer Therapeutics at The University of Texas MD Anderson Cancer Center between 2021 to 2022, where she studied synthetic lethal strategies in drug development.
Dr Ngoi has an interest in clinical and translational research in Gynaecologic Oncology. She has multiple publications in peer-reviewed journals in this area and is an invited journal reviewer in this field. She serves as an active member of the Gynecologic Cancer Group Singapore and Asia Pacific Gynecologic Oncology Trials Group.
